This funding opportunity announcement (FOA) issued by National Heart, Lung, and Blood Institute (NHLBI) invites applications to conduct functional analyses…
GlaxoSmithKline committed to provide researchers with unmatched access to patient-level data from its clinical trials--including studies that failed. The move…